Emergent BioSolutions (EBS) shares gained more than 11% in recent Monday trading after HC Wainwright began coverage of the stock at buy with a $15 price target.
The company's trading volume stood at nearly 892,000 shares against a daily average of roughly 1.3 million.
Shares of Emergent BioSolutions were recently up 11.3% at $9.20.
Price: 9.15, Change: +0.88, Percent Change: +10.60
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。